Eli Lilly (NY:LLY)

Animal health company Elanco (NYSE:ELAN) will be announcing earnings results tomorrow before market open. Here’s what to look for.

Elanco (ELAN) Q4 Earnings Report Preview: What To Look For

February 24, 2025

Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) will be reporting earnings tomorrow after the bell. Here’s what to look for.

Jazz Pharmaceuticals (JAZZ) Reports Earnings Tomorrow: What To Expect

February 24, 2025

ELI LILLY & CO (NYSE:LLY) is a candidate for high growth investors. Here's why. Full fundamental and technical analysis of (NYSE:LLY).

Unlocking the high Growth Potential of NYSE:LLY.

February 24, 2025

Via Chartmill

Wall Street Thinks This Weight-Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk

February 24, 2025

Eli Lilly's Options Frenzy: What You Need to Know

February 20, 2025

Via Benzinga

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

February 14, 2025

Via Benzinga

GLP-1 Drugs Drive Growth for Eli Lilly. Is the Stock a Buy?

February 13, 2025

President Donald Trump has issued a stringent warning to pharmaceutical companies, advising them to repatriate their manufacturing to the US or face the possibility of tariffs.

Trump Reportedly Warns Big Pharma: Move Manufacturing To US Or Face Tariffs

February 24, 2025

Via Benzinga

Topics Government

3 Magnificent Growth Stocks to Buy Right Now

February 22, 2025

UNH is trimming its losses, 95% of the reason I didn’t take instant triple-digit profits is because the Wing Sting is so severe. United Healthcare is FAR from being done getting smashed in the face.

In Flight Dining

February 21, 2025

Via Talk Markets

Topics Stocks / Equities

Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage

February 21, 2025

The FDA said the shortages in Novo Nordisk's weight-loss drug has been resolved.

Via Investor's Business Daily

Eli Lilly (LLY): Buy, Sell, or Hold Post Q4 Earnings?

February 21, 2025

Over the past six months, Eli Lilly’s stock price fell to $872.91. Shareholders have lost 8.3% of their capital, which is disappointing considering the S&P 500 has climbed by 8.9%. This might have...

Eli Lilly Remains JPMorgan's Top Biopharma Pick For 2025, But Gilead And Bristol Myers Also Gain Praise — Is Retail On Board?

Topics Stocks

February 21, 2025

JPMorgan sees Gilead well-positioned due to its strong HIV drug portfolio and disciplined expense management.

Via Stocktwits

Large Cap Biopharmaceutical Metrics And Performance Q1 2025

February 20, 2025

Tariffs could have big impact on earnings in 2025.

Via Talk Markets

Topics Stocks / Equities

Biogen Stock Is Mutating Into a Value Play

February 20, 2025

Biogen shares have fallen over 70% from its highs nearly 12-years ago, but value investors should take a look at its metrics of just 12.4 P/E and P/B of 1.2X

The big game didn't live up to the big billing, but there was plenty to take in during commercial breaks and halftime.

Digesting Super Bowl Ads, Dunkin' & Starbucks Plans, and Some Weight Loss Drug News

February 19, 2025

Digging Into What Hershey and Eli Lilly Told Investors

February 19, 2025

After a massive 500% run over the past 12 months, shares of Hims & Hers stock might have another trick saved up before earnings announcements.

Hims & Hers Earnings Could Be a Game Changer—What to Do Now

February 18, 2025

It may be early, but some blazing investments have already delivered wealth-altering gains in this young year.

3 Hot Stocks That Have Already Doubled in 2025

February 18, 2025

The stock isn't as expensive as you might think.

Hims & Hers Stock Is On Fire, But Is It a Bubble?

February 18, 2025

FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes

February 18, 2025

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

Via Benzinga

Billionaire Investor Stanley Druckenmiller Dumps Broadcom, Bets Big On Tesla, Amazon And Other Big Tech Stocks In Q4

February 18, 2025

Billionaire investor Stanley Druckenmiller's family office Duquesne has divested his entire stake in Broadcom, simultaneously increasing his investments in major tech companies, as revealed in a recent...

Via Benzinga

Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for Investors

February 17, 2025

Ken Griffin's Citadel hedge fund places £305M short bet against GSK, with skepticism over long-term pipeline and recent stock rally.

Via Benzinga

Novo Nordisk Shares Near New 52-Week Low: Analysts See Big Upside

February 17, 2025

Novo Nordisk shares are closing in on a new 52-week low. Is the stock gearing up for a recovery with sentiment currently low?

3 Stocks That Could Trounce the Market in 2025

February 17, 2025

Think Eli Lilly's Stock Is Expensive? Here's Why Selling It Now Could Be a Huge Mistake

February 15, 2025

Despite many negative headlines, stocks are trading near all-time highs; next week will be a shortened trading week, with most of the monthly economic data in

MarketBeat Week in Review – 02/10 - 02/14

February 15, 2025

Today's Research Daily features new research reports on 16 major stocks, including Apple Inc., Eli Lilly and Co., and Shopify Inc., as well as a micro-cap stock ImmuCell Corp.

Topics Credit Cards Economy Government

Top Stock Reports For Apple, Eli Lilly & Shopify

February 14, 2025

Via Talk Markets

Topics Stocks / Equities

Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial

February 13, 2025

Eli Lilly is still seeing rapid sales growth for its diabetes and weight loss drugs. However, one drug waiting in the wings hopes to be its next blockbuster.